CYDAN
Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.
CYDAN
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cydanco.com
Total Employee:
11+
Status:
Active
Contact:
617-230-3010
Total Funding:
60 M USD
Technology used in webpage:
SPF Amazon Microsoft Azure DNS Amazon Virginia Region Gravity Forms Network Solutions DNS Mimecast
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Venture Round - Cydan
Longitude Capital
Longitude Capital investment in Venture Round - Cydan
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Venture Round - Cydan
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Cydan
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Cydan
Bay City Capital
Bay City Capital investment in Venture Round - Cydan
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Venture Round - Cydan
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Cydan
Alexandria Venture
Alexandria Venture investment in Venture Round - Cydan
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Cydan
Newest Events participated
Official Site Inspections
http://www.cydanco.com
- Host name: 172.67.201.192
- IP address: 172.67.201.192
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cydan"
Cydan - Crunchbase Company Profile & Funding
Organization. Cydan . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number …See details»
Cydan Company Profile - Office Locations, Competitors, Revenue …
Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path …See details»
Cydan Company Profile 2024: Valuation, Funding & Investors
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20210338782-A1: Storage stable somatostatin-dopamine chimeric compounds and salt forms thereofSee details»
Working at Cydan Development, Inc. - Zippia
Mar 14, 2024 www.cydanco.com. Organization Type. Private. Cydan Development, Inc. is a small pharmaceutical company based in Cambridge, MA with only 50 employees and an …See details»
Cydan Company Profile: Overview and Full News Analysis
Cydanco.com. Overview: Cydan. Cydan is a Massachusetts-based company focused on accelerating the development of therapies for rare genetic diseases, excluding oncology. With …See details»
www.cydanco.com
Www.cydanco.comSee details»
Cydan CEO and Key Executive Team | Craft.co
Cydan's Founder, Chief Executive Officer & Director is Chris Adams. Other executives include Imran Babar, Chief Business Officer; Sandip K. Agarwala, Director and 5 others. See the full …See details»
Cydan - VentureRadar
Open PageRank: 7,643,011 | cydanco.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times …See details»
Cydan Announces Formation of Tiburio Therapeutics Inc. to …
Jan 4, 2019 For more information, visit cydan.com or contact the company at [email protected]. Related news. Acacia Pharma Group PLC proposed Transaction with …See details»
Cydan Raises $34 Million to Accelerate New Treatments
Oct 17, 2017 Cydan announced a new round of financing, raising a committed $34 million to advance the company’s mission to create new treatments for rare diseases.See details»
Orphan Drug Accelerator Cydan Expands Transactional Expertise …
Oct 17, 2014 There are nearly 7,000 recognized rare diseases affecting nearly 30 million Americans and an estimated 350 million people worldwide, according to the National …See details»
Cydan Expands Team to Accelerate Development of Innovative
Mar 20, 2019 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of people living with rare genetic …See details»
Home – Cyanco
Cyanco produces and distributes more high-quality solution and solid sodium cyanide than anyone else in the world. As the industry’s premiere supplier, our portfolio of Applied …See details»
Cyanco - Crunchbase Company Profile & Funding
Cyanco produces and supplies sodium cyanide for gold and silver mining, in both liquid and solid forms.See details»
Cyanco Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, investors, and executives for Cyanco. Use the PitchBook Platform to explore the full profile.See details»
Cydan Raises $34 Million to Accelerate New Treatments for Rare …
Oct 18, 2017 Funds further company’s mission to identify and de-risk preclinical rare disease therapeutics, ultimately, spinning out companies with IND-ready programs – Cydan expands …See details»
Cyanco and Cycladex Announce Strategic Technology …
Cyanco and Cycladex Announce Strategic Technology Commercialization Partnership Joint goal to further develop an additional environmentally-friendly gold recovery technology Houston, …See details»
Orica to acquire Cyanco creating global sodium cyanide major for …
Feb 21, 2024 International Mining Team Publishing Ltd 2 Claridge Court, Lower Kings Road Berkhamsted, Hertfordshire England HP4 2AF, UK. Tel: +44 (0) 1442 870 829See details»
Company Fact Sheet - Cyanco
HISTORICAL TIMELINE » Cyanco was formed in 1990, as the result of a merger between Alta Gold and MSI Group. » The company’s original purpose was to provide sodium cyanide in a …See details»
About Us - Cyanco
In Houston, we are supporting the ‘Kids Meals’ organization, which is currently delivering over 6,000 meals/day to children in at-risk communities. These children, who are sheltering in place …See details»